3 November 2022
Clifford Chance advises Gilde Healthcare on the financing of its acquisition of Sanquin Reagents
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Boudewijn Vermeer Lead | Clifford Chance | Not stated | Not stated | Not stated |
| Daniela Chilkevitsh | Clifford Chance | Not stated | Not stated | Not stated |
| Inge de Bruin | Clifford Chance | Not stated | Not stated | Not stated |
| Robin Houtveen | Clifford Chance | Not stated | Not stated | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Not stated
- Counterparties
- Sanquin Reagents (Target)
LGT Capital Partners (Lenders)